Perioperative management of phaeochromocytoma

Acta Anaesthesiologica Belgica

Volumn 60, Issue 1, 2009, Pages 55-66

  Van Braeckel, Pieter ^a   Carlier, S ^a   Steelant, P J ^a   Weyne, L ^a   Vanfleteren, L ^a  

^a AZ Groeninge ^*  (Belgium)

Author keywords

Adrenal gland neoplasms; Alpha blockade; Anaesthesia; Catecholamine; Intraoperative care; Magnesium sulphate; Phaeochromocytoma; Postoperative care; Pregnancy; Preoperative care; Stress related cardiomyopathy; Tako Tsubo cardiomyopathy

Indexed keywords

ATENOLOL; BISOPROLOL; DOXAZOSIN; ESMOLOL; FENOLDOPAM MESILATE; FENTANYL; FLUDROCORTISONE; GLYCERYL TRINITRATE; HYDROCORTISONE; KETAMINE; LABETALOL; MAGNESIUM SULFATE; METHYLPREDNISOLONE; METIROSINE; NICARDIPINE; NITROPRUSSIDE SODIUM; NITROUS OXIDE; OPIATE; PETHIDINE; PHENOXYBENZAMINE; PHENTOLAMINE; PRAZOSIN; PREDNISOLONE; PREDNISONE; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; TERAZOSIN; UNINDEXED DRUG; URAPIDIL;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANESTHESIA INDUCTION; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOMYOPATHY; CARDIOVASCULAR EFFECT; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; ECHOCARDIOGRAPHY; EVENING DOSAGE; FLUSHING; GENE MUTATION; GENERAL ANESTHESIA; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; INTRAOCULAR PRESSURE; LOADING DRUG DOSE; MONOTHERAPY; MORNING DOSAGE; NONHUMAN; OLIGURIA; PERIOPERATIVE PERIOD; PERIPHERAL EDEMA; PEROPERATIVE CARE; PHEOCHROMOCYTOMA; PREGNANCY; PREOPERATIVE EVALUATION; PREVALENCE; REVIEW; SIDE EFFECT; TACHYCARDIA; UNSPECIFIED SIDE EFFECT;

ADRENAL GLAND NEOPLASMS; ANESTHESIA, GENERAL; FEMALE; HUMANS; HYPERTENSION; MONITORING, INTRAOPERATIVE; PERIOPERATIVE CARE; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RARE DISEASES;

EID: 65649124576     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Lenders J., Eisenhofer G., et al., Phaeochromocytoma, THE LANCET, 366, 665-675, 2005.
2. Crout R., Sjoerdsma A., Catecholamines in the localisation of pheochromocytoma, CIRCULATION, 22, 516-525, 1960.
3. James M. F., Crojé L., Pheochromocytoma crisis: The use of magnesium sulfate, ANESTIL ANALG., 99, 680-686, 2004.
4. Engelman K., Phaeochrvmocytoma, CLIN. ENDOCRINOL. METAB., 6, 769-97, 1977.
5. Welbourn R. B., Early surgical history of phaeochromocytoma, BR. J. SURG., 74, 594-596, 1987.
6. Kercher K., Novitsky Y., et al., Laparoscopic curative resection of pheochromocytoma, ANNALS OF SURGERY, 241 (6), 919-928, 2005.
7. Kinney M., Warner M., et al., Perianesthetic risks and outcomes of pheochromocytorna and paraganglioma resection, ANESTH. ANALG., 91, 1118-23, 2000.
8. Prys-Roberts C., Phaeochrvmocytoma - recent progress in its management, BR. J. ANAESTH., 85, 44-57, 2000.
9. Lo C. Y, Lam K. Y., et al., Adrenal pheochromocytoma remains a frequently overlooked diagnosis, AM J. SURG., 179, 212-15, 2000.
10. Kinney M., Badly J., et al., Perioperative management of pheochromocytoma, JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 16, 359-369, 2002.
11. Batide-Alanore A., Chatellier G., et al., Diabetes as a marker of phaeochromocytoma in hypertensive patients, J. HYPERTENS, 21, 1703-07, 2003.
12. Braunwald E., Fauci A. S., et al., Harrison's Principles of Internal Medicine, McGraw-Hill, 15th edition, 2108, 2001.
13. Whitman H. H., Fishman E., et al., Catecholamine-Secreting Metastatic Carcinoid as Differential Diagnosis in Pheochromocytoma, Issue Pheochromocytoma. First International Symposium, New York Academy of Sciences, 59-78, published online 7 Sep 2006.
14. Golbasi Z., Murat S., et al., Dynamic ventricular ouoqow tract obstruction in a patient with pheochromocytoma, JAPANESE HEART JOURNAL, 40 (6), 831-835, 1999.
15. Huddle K. R., Kalliatakis B., et al., Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy, CHEST, 109, 1394-1397, 1996.
16. Attar M. N., Moulik P. K., et al., Phaeochormocytoma presenting as dilated cardiomyopathy, INT. J. CLIN. PRACT., 57 (6), 547-548, 2003.
17. Salathe M., Weiss P., et al., Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril, BR. HEART J., 68, 527-528, 1992.
18. Nanda S., Bhatt S. P., Dale T. H., Takotsubo cardiomyopathy - A new variant and widening disease spectrum. Ιnverted takotsubo" pattern related to catecholamine toxicity, INT. J. CARDIOL., Jan 21 [Epub ahead of print], 2008.
19. Brenner Z. R., Powers J., Takotsubo cardiomyopathy, HEART&LUNG: THE JOURNAL OF ACUTE AND CRITICAL CARE, 37 (1), 1-7, 2008.
20. Sanchez-Recalde A., Costero O., et al., Pheochromocytoma-related cardiomyopathy, CIRCULATION, 113, 738-739, 2006.
21. Von Bergen N. H., Lyon J. K., et al., Takotsubo-Like Cardiomyopathy in a 17-Year-Old male with a Pheochromocytoma, PEDIATRIC CARDIOLOGY, published online Aug 15 2008.
22. Zegdi R., Parisot C., et al., Pheochromocytoma-induced inverted Takotsubo cardiomyopathy: A case of patient resuscitation with extracorporeal life support, THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 135, 434-435, 2008.
23. Kimura S., Mitsuma W., et al., Inverted Takotsubo contractile pattern caused by pheochromocytoma with tall upright T waves, but not typical deep T-wave inversion, INT. J. CARDIOL., [Epub ahead of print], Aug 20, 2008.
24. Dimski T., Heine-Lauten J., et al., Basal tako-tsubo cardiomyopathy, Induction of a pheochromocytoma after general anesthesia, ANESTHESIST, 57 (2), 143-146, 2008.
25. Koeth O., Mark B., et al., Cardiogenic shock after adrenalectomy for pheochromocytoma, INTERNIST (Berl.), 48 (2), 189-93, 2007.
26. Itsuko M., Atsuyuku W., et al., Emerging acute unilateral pulmonary edema in a patient with pheochromocytoma, INTERNATIONAL JOURNAL OF CARDIOLOGY, available online 8 January 2008.
27. Boutros A. R., Bravo E. L., Zanettin G., et al., Perioperative management of 63 patients with pheochromocytoma, CLEVE CLIN. J. MED., 57, 613-617, 1990.
28. Steinsapir J., Carr A. A., Prisant L. M., et al., Metyrosine and pheochromocytoma, ARCH. INTERN. MED., 157, 901-906, 1997.
29. Witteles R., Kaplan E., et al., Safe and Cost-effective preoperative preparation of patients with pheochromocytoma, ANESTH. ANALG., 91, 302-304, 2000.
30. Stenström G., Kutti J., The blood volume in pheochromocytoma patients before and during treatment with phenoxybenzamine, ACTA MED. SCAND., 218 (4), 381-7, 1985.
31. http://www.drugs.com/
32. Prys-Roberts C., Farndon J. R., Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma, WORLD JOURNAL OF SURGERY, 26 (8), 1037-1042, 2002.
33. Pan D. L., Li H. Z., Effects of doxazosin mesylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: A comparative study in 38 cases, ZHONGHUA YI XUE ZA ZHI, 85 (20), 1403-5, 2005.
34. Chi-Ho Chung P., Ng Y. T., et al., Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma, J. FORMOS MED. ASS., 105 (4), 189-193,2006.
35. Feek C. M., Earnshaw P. M., Hypertensive response to labetalol in phaeochromocytoma, BRITISH MEDICAL JOURNAL, 387, 1980.
36. Sloand E. M., Thompson B. T., Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma, ARCH. INTERN. MED., 144, 173-174, 1984.
37. http://www.bcfi.be
38. Roizen M. F., Schreider B. D., Hassan S. Z., Anesthesia for patients with pheochromocytoma, ANESTHESIOL CLIN. NORTH AM., 5, 269-275, 1987.
39. Pacak K., Marston W., Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma, ANNALS OF INTERNAL MEDICINE, 134 (4), 315-329, Feb 2001.
40. Aplin S. C., Yee K. E, et al., Neonatal effect of long-term maternal phenoxybenzamine therapy, ANESTHESIOLOGY, 100, 1608-1610, 2004.
41. Kim P. T. W., Kreisman S. H., et al., Laparoscopic adrenalectomy for pheochromocytoma in pregnancy, J. CAN. CHIR., 49 (1), 2006.
42. Hamilton A., Sirrs S., et al., Anesthesia for phaeochromocytoma in pregnancy, CAN. J. ANAESTH., 44, 654, 1997.
43. Dougherty T. B. Cronau L. H., Anesthetic implications for surgical patients with endocrine tumors, INT. ANESTHESIOL. CLIN., 36, 31-44, 1998.
44. Ryan T., Timoney A., et al., Use of transoesophageal echocardiography to manage beta-adrenoceptor block and assess left ventricular function in a patient with phaeochromocytoma, BR. J. ANAESTH., 70 (1), 101-3, 1993.
45. Miller R. D., Anesthesia, 4th, edition, New York, Churchill Livingstone, 903-1014, 1994.
46. Humphrey R., Gray D., et al., Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: A review of 47 cases, CAN. J. SURG., 51 (4), 276-280, 2008.
47. Joris J. L., Hamoir E. E., et al., Hemodynamic changes and catecholamine release during laparascopic adrenalectomy for pheochromocytoma, ANESTH. ANALG., 88, 16-21, 1999.
48. Takita K., Morimoto Y, et al., Tracheal lidocain attenuates the cardiovascular response to endotracheal intubation, CANADIAN JOURNAL OF ANESTHESIA, 48, 732-736, 2001.
49. Minogue S. C., Ralp J., et al., Laryngotacheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia, ANESTH. ANALG., 99, 1253-1257, 2004.
50. Harris C. E., Murray A. M., et al., Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation, ANAESTHESIA, 43, 32-36, 1988.
51. Bouloux P. M., Grossman A., et al., Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas, CLIN. ENDOCRINOL. (Oxf)., 24 (3), 319-25, 1986.
52. Dermitzaki E., Gravanis A., et al., Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actinfilaments, ENDOCRINOLOGY, 142, 2022-2031, 2001.
53. Barash P. G., Cullen B. F., Stoelting R. K., CLINICAL ANESHESIA, 5th edition, Philadelphia, Lippincott Williams & Wilkins, 371-375, 2006.
54. Dimitriou V., Chantzi C., et al., Remifentanil preventing hemodynamic changes during laparascopic adrenalectomy for pheochromocytoma, MIDDLE EAST J. ANAESTHESIOL., 18 (5), 947-954, 2006.
55. Ip-Yam P. C, Ruban P., et al., Remifentanil in the management of laparoscopic resection of phaeochromocytoma-case reports, ANN. ACAD. MED. SINGAPORE, 32 (6), 828-831, 2003.
56. Breslin DS., Farling PA., Mirakhur RK., The use of remifentanil in the anaesthetic management of patients undergoing adrenalectomy: A report of three cases, ANESTHESIA, 58 (4), 358-62, 2003.
57. Barash P. G., Cullen B. F., Stoelting R. K., CLINICAL ANESHESIA, 5th edition, Philadelphia, Lippincott Williams & Wilkins, 1143-1145, 2006.
58. de La Chapelle A., Deghmani M., Dureuil B., Peritoneal insufflation can be a critical moment in laparascopic surgery of pheochromcytoma, ANN. FR. ANESTH. REANIM., 17, 1184-1185, 1998.
59. Walder A. D., Aitkenhead A. R., Role of vasopressin in the haemodynamic response to laparoscopic cholecystectomy, BR. J. ANAESTH., 78, 264-266, 1997.
60. Anton A. H., Sherman B. W., et al., An atrial pheochromocytoma-induced crisis resistant to nitroprusside, INT. J. CLIN. PHARMCOL. THER. TOXICOL., 31, 89-92, 1993.
61. Niruthisard S., Chatrkaw P., et al., Anesthesia for one-stage bilateral pheochromocytoma resection in a patient with MEN type IIa: attenuation of hypertensive crisis by magnesium sulphate, J. MED. ASSOC. THAI, 85, 125-130, 2002.
62. I block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, BRITISH JOURNAL OF ANAESTHESIA, 92 (4), 512-517, 2004.
63. Steib A., Collin F., et al., Use of urapidil during surgery for pheochromocytoma, ANN. FR. ANESTH. REANIM., 15 (2), 142-148, 1996.
64. Cooper Z. A., Mihm E G., Blood pressure control with fenoldopam during excision of a pheochromocytoma, ANESTHESIOLOGY, 91 (2), 558-560, 1999.
65. Chung R, Li A., et al., Elevated vascular resistance after labetalol during resection of a pheochromocytoma, CAN. J. ANAESTH., 49, 148-150, 2002.
66. Masumune T., Ishiyama T., et al., Use of magnesium sulphate during resection of pheochromocytoma, MASUI, 51, 515-517, 2002.
67. Pitt-Miller P., Primus E., Use of magnesium sulphate as adjunctive therapy for resection of pheochromocytoma, WEST INDIAN MED. J., 49, 73-75, 2000.
68. James M. F., Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: A review of 17 anaesthetics, BR. J. ANAESTH., 62 (6), 616-623, 1989.
69. Drolet P., Girard M., The use of magnesium sulfate during surgery of pheochromocytoma: Apropos of 2 cases, CAN. J. ANAESTH., 6, 521-525, 1993.
70. Evan G. P., Magnesium sulfate and epidural anaesthesia in pheochromocytoma and severe coronary artery disease, ANESTH. ANALG., 81, 414-416, 1995.
71. Toshitaka M., Takehiko A., et al., An effective use of magnesium sulfate for intraoperative management of laparoscopic adrenatectomy for pheochromocytoma in a pediatric patient, ANESTH. ANALG., 95, 1243-1244, 2002.
72. Zakowski M., Kaufman B., et al., Esmolol use during resection of pheochromocytoma: Report of three cases, ANESTHESIOLOGY, 70, 875-877, 1989.
73. Lairmore T. C., Ball D. W., et al., Management of pheochromocytoma in patients with multiple endocrine neoplasia type 2 syndromes, ANN. SURG., 217, 595-603, 1993.
74. Shen W. T., Lee J., et al., Selective use of steroid replacement after adrenalectomy-Lessons from 331 consecutive cases, ARCH. SURG., 141, 771-776, 2006.
75. Khorram-Manesh A., Ahlman H., et al., Long term outcome of a large series of patients surgically treated for pheochromocytoma, JOURNAL OF INTERNAL MEDICINE, 258, 55-66, 2005.